T. Rowe Price U.S. Equity Research Fund, Inc. - T. Rowe Price U.S. Equity Research Fund (PRCO.X)

Basic

  • Market Cap

    $12.72B

  • EV

    $12.67B

  • Shares Out

    284.43M

  • Revenue

    $172.12M

  • Employees

    —

Margins

  • Gross

    100%

  • EBITDA

    —

  • Operating

    85.37%

  • Pre-Tax

    1,356.65%

  • Net

    1,356.65%

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    0.76%

  • ROE

    7.44%

  • ROCE

    1.22%

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $0.61

  • Earnings (Dil)

    $8.21

  • FCF

    —

  • Book Value

    $43.13

Growth (CAGR)

  • Rev 3Yr

    51.55%

  • Rev 5Yr

    74.29%

  • Rev 10Yr

    34.36%

  • Dil EPS 3Yr

    88%

  • Dil EPS 5Yr

    20.24%

  • Dil EPS 10Yr

    10.42%

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    5.6%

  • DPS

    $0.46

  • DPS Growth 3Yr

    15.31%

  • DPS Growth 5Yr

    -24.13%

  • DPS Growth 10Yr

    7.18%

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Interest And Invest. Income

14.5

22.9

73.0

92.6

156.7

172.1

Total Revenues

14.5

22.9

73.0

92.6

156.7

172.1

Total Revenues % Chg.

44.7%

58.1%

218.7%

26.7%

69.3%

40.0%

Gross Profit

14.5

22.9

73.0

92.6

156.7

172.1

Selling General & Admin Expenses, Total

3.5

4.6

12.8

24.5

26.1

25.2

Other Operating Expenses, Total

3.5

4.6

12.8

24.5

26.1

25.2

Operating Income

11.0

18.3

60.3

68.1

130.6

146.9

Currency Exchange Gains (Loss)

—

—

—

-0.0

0.0

0.0

Other Non Operating Income (Expenses)

-1.5

-0.7

-0.9

5.5

-15.6

-1.2

EBT, Excl. Unusual Items

9.5

17.6

59.4

73.6

115.0

145.7

Gain (Loss) On Sale Of Investments

-51.4

345.1

901.6

1,803.2

-2,330.0

2,189.3

EBT, Incl. Unusual Items

-41.9

362.7

960.9

1,876.8

-2,214.9

2,335.0

Earnings From Continuing Operations

-41.9

362.7

960.9

1,876.8

-2,214.9

2,335.0

Net Income

-41.9

362.7

960.9

1,876.8

-2,214.9

2,335.0

Net Income to Common Incl Extra Items

-41.9

362.7

960.9

1,876.8

-2,214.9

2,335.0

Net Income to Common Excl. Extra Items

-41.9

362.7

960.9

1,876.8

-2,214.9

2,335.0

Total Shares Outstanding

29.9

100.5

160.6

209.8

313.4

284.4

Weighted Avg. Shares Outstanding

29.9

100.5

160.6

209.8

313.4

284.4

Weighted Avg. Shares Outstanding Dil

29.9

100.5

160.6

209.8

313.4

284.4

EPS

-1.4

3.6

6.0

8.9

-7.1

8.2

EPS Diluted

-1.4

3.6

6.0

8.9

-7.1

8.2